250 related articles for article (PubMed ID: 12644008)
1. Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
Chin BS; Langford NJ; Nuttall SL; Gibbs CR; Blann AD; Lip GY
Eur J Heart Fail; 2003 Mar; 5(2):171-4. PubMed ID: 12644008
[TBL] [Abstract][Full Text] [Related]
2. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Chin BS; Gibbs CR; Blann AD; Lip GY
Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
Gibbs CR; Blann AD; Watson RD; Lip GY
Circulation; 2001 Apr; 103(13):1746-51. PubMed ID: 11282905
[TBL] [Abstract][Full Text] [Related]
4. Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
Cugno M; Agostoni P; Mari D; Meroni PL; Gregorini L; Bussotti M; Anguissola GB; Donatelli F; Nussberger J
Br J Haematol; 2005 Jul; 130(1):113-20. PubMed ID: 15982353
[TBL] [Abstract][Full Text] [Related]
5. Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress.
Ellis GR; Nightingale AK; Blackman DJ; Anderson RA; Mumford C; Timmins G; Lang D; Jackson SK; Penney MD; Lewis MJ; Frenneaux MP; Morris-Thurgood J
Eur J Heart Fail; 2002 Mar; 4(2):193-9. PubMed ID: 11959049
[TBL] [Abstract][Full Text] [Related]
6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
7. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
[TBL] [Abstract][Full Text] [Related]
8. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
11. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
[TBL] [Abstract][Full Text] [Related]
12. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
13. Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure.
Castro P; Vukasovic JL; Chiong M; Díaz-Araya G; Alcaino H; Copaja M; Valenzuela R; Greig D; Pérez O; Corbalan R; Lavandero S
Eur J Heart Fail; 2005 Oct; 7(6):1033-9. PubMed ID: 16227141
[TBL] [Abstract][Full Text] [Related]
14. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
Ter Arkh; 2006; 78(9):61-71. PubMed ID: 17076227
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
Ethn Dis; 2003; 13(1):71-9. PubMed ID: 12723015
[TBL] [Abstract][Full Text] [Related]
16. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
Fowler MB
Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers in heart failure. The 'new wave' of clinical trials.
Krum H
Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
[TBL] [Abstract][Full Text] [Related]
18. Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.
Düngen HD; Apostolović S; Inkrot S; Tahirović E; Krackhardt F; Pavlović M; Putniković B; Lainscak M; Gelbrich G; Edelmann F; Wachter R; Eschenhagen T; Waagstein F; Follath F; Rauchhaus M; Haverkamp W; Osterziel KJ; Dietz R;
Clin Res Cardiol; 2008 Sep; 97(9):578-86. PubMed ID: 18542839
[TBL] [Abstract][Full Text] [Related]
19. Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockers.
Vittorio TJ; Lang CC; Katz SD; Packer M; Mancini DM; Jorde UP
Circulation; 2003 Jan; 107(2):290-3. PubMed ID: 12538430
[TBL] [Abstract][Full Text] [Related]
20. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
